NIH awards contracts for COVID-19 rapid point-of-care tests
The National Institutes of Health last week announced as part of its Rapid Acceleration of Diagnostics initiative $129.3 million in contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours.
Among the tests are some that use RT-PCR and a device that can give results in 15 minutes and strips that can be read without specialized equipment, similar to pregnancy tests.
In addition, NIH said it is adding five additional laboratories to expand the network of coverage and potentially manage tens of thousands of additional tests daily.
Related News Articles
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The National Emerging Special Pathogens Training and Education Center announced Oct. 15 that it will award $37.5 million in grants to 75 hospitals seeking to…